Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Herpes Zoster × Vaccines × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 6 Condylomata Acuminata 3 Uterine Cervical Neoplasms 2 Anus Neoplasms 2 Whooping Cough 1 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Tetanus 1 Neoplasms, Glandular and Epithelial 1 Meningitis 1 Herpes Zoster 1 HIV Infections 1 Diphtheria 1

Interventions

Vaccines 1 Herpes Zoster Vaccine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01798056 2021-05-13

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy

GlaxoSmithKline

Phase 3 Completed

237 enrolled 20 charts

Herpes Zoster

Data powered by HemOnc (CC BY 4.0) Colophon ⚡